Stay updated on Relatlimab + Nivolumab Bioavailability Clinical Trial

Sign up to get notified when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab + Nivolumab Bioavailability Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, blocking access to the NCT04112498 record and its details on ClinicalTrials.gov.
    Difference
    17%
    Check dated 2026-09-20T00:23:28.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing v3.6.5, signaling a backend/content management update to the page. This change does not affect the study data or its presentation.
    Difference
    0.1%
    Check dated 2026-08-29T20:29:48.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This signals a content update to the latest version.
    Difference
    0.1%
    Check dated 2026-08-08T17:06:00.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the page template/backend used to render the Study Details page.
    Difference
    0.1%
    Check dated 2026-07-25T09:23:55.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.2 to v3.6.3, indicating a new build of the ClinicalTrials.gov page. This update likely reflects maintenance or improvements without changing the underlying study information.
    Difference
    0.1%
    Check dated 2026-07-03T21:48:56.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Sponsor branding and new information sections (BMS Clinical Trial Information and Patient Recruiting) were added, along with related drug names and FDA-regulated status indicators. These updates clarify who runs the study and where to find participation details.
    Difference
    46%
    Check dated 2026-06-26T19:48:17.000Z thumbnail image

Stay in the know with updates to Relatlimab + Nivolumab Bioavailability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.